These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R. Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395 [Abstract] [Full Text] [Related]
26. Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing. Donáth J, Speer G, Kósa JP, Árvai K, Balla B, Juhász P, Lakatos P, Poór G. Croat Med J; 2015 Apr; 56(2):145-51. PubMed ID: 25891874 [Abstract] [Full Text] [Related]
27. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. Brunetti G, Marzano F, Colucci S, Ventura A, Cavallo L, Grano M, Faienza MF. Endocrine; 2012 Oct; 42(2):266-71. PubMed ID: 22638612 [Abstract] [Full Text] [Related]
28. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J. Hum Mol Genet; 2002 Sep 01; 11(18):2119-27. PubMed ID: 12189164 [Abstract] [Full Text] [Related]
29. Rare Inherited forms of Paget's Disease and Related Syndromes. Ralston SH, Taylor JP. Calcif Tissue Int; 2019 May 01; 104(5):501-516. PubMed ID: 30756140 [Abstract] [Full Text] [Related]
32. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. Beyens G, Daroszewska A, de Freitas F, Fransen E, Vanhoenacker F, Verbruggen L, Zmierczak HG, Westhovens R, Van Offel J, Ralston SH, Devogelaer JP, Van Hul W. J Bone Miner Res; 2007 Jul 01; 22(7):1062-71. PubMed ID: 17388729 [Abstract] [Full Text] [Related]
33. Paget's disease of bone: experience from a centre in southern India. Anjali, Thomas N, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS. J Assoc Physicians India; 2006 Jul 01; 54():525-9. PubMed ID: 17089899 [Abstract] [Full Text] [Related]
34. SQSTM1 and Paget's disease of bone. Layfield R, Hocking LJ. Calcif Tissue Int; 2004 Nov 01; 75(5):347-57. PubMed ID: 15365659 [Abstract] [Full Text] [Related]
36. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Abelson A. Curr Med Res Opin; 2008 Mar 01; 24(3):695-705. PubMed ID: 18226324 [Abstract] [Full Text] [Related]
38. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Lucas GJ, Mehta SG, Hocking LJ, Stewart TL, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Watts GD, Ralston SH, Kimonis VE. Bone; 2006 Feb 01; 38(2):280-5. PubMed ID: 16199218 [Abstract] [Full Text] [Related]
39. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. Nakatsuka K, Nishizawa Y, Ralston SH. J Bone Miner Res; 2003 Aug 01; 18(8):1381-5. PubMed ID: 12929927 [Abstract] [Full Text] [Related]
40. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin. Bock O, Loch G, Schade U, Büsche G, Wasielewski R, Wiese B, Kreipe H. Br J Haematol; 2005 Jul 01; 130(1):76-82. PubMed ID: 15982347 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]